New Similac 360 Total Care Made With Whole Milk combines creamy whole milk for a fat blend that more

Fairtree Asset Management Pty Ltd purchased a new position in shares of Abbott Laboratories (NYSE: A

Advisors Capital Management LLC purchased a new position in Abbott Laboratories (NYSE: ABT) during t

Callan Family Office LLC acquired a new stake in shares of Abbott Laboratories (NYSE: ABT) during th

Burnham and Co LLC bought a new stake in shares of Abbott Laboratories (NYSE: ABT) in the undefined

E Fund Management Co. Ltd. bought a new position in shares of Abbott Laboratories (NYSE: ABT) during

Frazier Financial Advisors LLC bought a new stake in Abbott Laboratories (NYSE: ABT) during the seco

CM Wealth Advisors LLC acquired a new stake in Abbott Laboratories (NYSE: ABT) during the second qua

BlackRock Inc. increased its holdings in Abbott Laboratories (NYSE: ABT) by 4.6% in the undefined qu

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

AMG National Trust Bank decreased its stake in Abbott Laboratories (NYSE: ABT) by 30.6% in the undef

Abbott (ABT) concluded the recent trading session at $111.59, signifying a -2.2% move from its prior

Abbott just scored a regulatory first in diabetes care that no rival has matched, yet the stock sits

Amulet 360 helps seal the left atrial appendage (LAA) of a person's heart, reducing the need for blo

Bank of New York Mellon Corp lessened its stake in shares of Abbott Laboratories (NYSE: ABT) by 19.7

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton

Bank Hapoalim BM boosted its holdings in Abbott Laboratories (NYSE: ABT) by 80.7% in the undefined q

The U.S. Food and Drug Administration said on Tuesday it authorized Abbott Laboratories' glucose mon

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for peopl

Libre Duo 10 Day is a first-of-its-kind, two-in-one biowearable that monitors glucose and helps dete

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation

Gateway Wealth Partners LLC lessened its stake in shares of Abbott Laboratories (NYSE: ABT) by 64.3%

Choreo LLC cut its position in Abbott Laboratories (NYSE: ABT) by 4.4% during the second quarter, ac

Golden Reserve Retirement LLC grew its holdings in Abbott Laboratories (NYSE: ABT) by 155.2% in the

Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott

ABT's Diagnostics growth is being reshaped as weaker respiratory testing offsets healthy routine dem

AbbVie and Abbott stand out as strong healthcare investments because they combine established busine

On August 24, 2026, we delve into the DCF analysis for Abbott Laboratories (ABT), a company currentl

Abbott agreed to pay $670 million to resolve the Gill lawsuit and 2,000 other NEC claims involving i

Abbott (NYSE: ABT) has reached agreements with three law firms to resolve the Gill case and claims i

HealthTab™ provides a complete, turnkey solution underpinning national pharmacy-based PoCT networks,

An official report on August 18, 2026 reveals Representative Rick Allen's recent sale of Abbott

Records from August 14, 2026 indicate that Representative Richard Dean Dr McCormick of Georgia made

A congressman reported selling stocks recently, while also investing in a municipal bond.

Wolfe Research analyst Mike Polark upgrades Abbott Laboratories (NYSE:ABT) from Peer Perform to O

The collaboration is designed to bring metabolic health insights into people's daily routines th

UBS analyst Patrick Wood maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price

Screening is for colorectal cancer (CRC) in adults 45 and older who are at average risk for the dise

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises t

Piper Sandler analyst Adam Maeder reiterates Abbott Laboratories (NYSE:ABT) with a Overweight and

JP Morgan analyst Robbie Marcus maintains Abbott Laboratories (NYSE:ABT) with a Overweight and ra

Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight an

TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintai

Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. A

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform

RBC Capital analyst Shagun Singh reiterates Abbott Laboratories (NYSE:ABT) with a Outperform and

Recent analyst rating changes, top names such as PPG, SAH, ISRG, MMM, OKE, GLDG, ABT, NFLX, TSCO, an

ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow